NEW YORK (GenomeWeb) – Vermillion today said that it has received a $7.5 million grant from the Cancer Prevention and Research Institute of Texas to support the firm's efforts in developing a multi-site pelvic mass registry.

The registry would contain data on patients undergoing evaluation, diagnosis, treatment, and follow up for pelvic masses that may lead to gynecologic malignancy. It would collect data from 10 hub sites that would manage patient enrollment regionally.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.